Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Home
▹
Exit Individual PI Data
Member Profile
Michael Brownlee
Personal Information
Title
Professor
Expertise
All Complications
Institution
Albert Einstein College of Medicine
Newsletter?
Not signed up.
Data Summary
Type
Count
Grants/SubContracts
1
Progress Reports
1
Publications
0
Protocols
0
Committees
1
Grants/Applications
Progress Reports
Publications
Presentations
Protocols
Committees
Mouse with inducible and reversible T1D for studying metabolic memory
The broad long term objective is to provide a unique type 1 diabetes model that can be used by the complications research community to study the molecular mechanisms underlying hyperglycemic memory. The Diabetes Control and Complications Trial (DCCT) showed that in people with short-duration type 1 diabetes, intensive glycemic control dramatically reduced the occurrence and severity of diabetic microvascular complications. The post-DCCT HbA1c values for the intensive and normal control groups soon became statistically identical and remained so during the years of follow-up in the ongoing Epidemiology of Diabetes Interventions and Complications Study (EDIC). Surprisingly, the effects of a 6.5-year difference in HbA1c during the DCCT on the rate of incidence of retinopathy and nephropathy have persisted. This phenomenon has been called “metabolic” or “hyperglycemic memory”. We urgently need to discover the molecular and cellular basis of hyperglycemic memory, so that we can design ways to prevent or reverse it. The research plan is to characterize the time course of doxycycline-dependent type 1 diabetes induction, reversal, and effect of duration on re-inducibility of diabetes in double transgenic mice expressing Kir 6.2 with the V59M gain-of-function mutation under the control of the tetracycline operator (tetO), and rat insulin promoter 2-driven rtTA. The inducible and reversible diabetes phenotype will be evaluated after 1, 3, and 5 months of diabetes, in each of these groups after 1 month of normal glucose metabolism, and in each of these groups after 1 month of normal glucose followed by 1 month of re-induced diabetes. Non-induced age-matched double transgenic and doxycycline exposed age-matched non-double transgenic littermates will be used as controls. Complete metabolic profiles of mice will be obtained for all the experimental groups. The effect of Kir6.2V59M-mediated diabetes induction and reversal on islet number, morphology, and insulin content will be evaluated by immunohistochemistry followed by morphometric analysis for all the experimental groups.
Progress Reports
Drag a column header and drop it here to group by that column
Application
Complete Date
Report
Options
Mouse with inducible and reversible T1D for studying metabolic memory (Brownlee, Michael)
10/22/2014
View Progress Report Document
Annual Reports
No uploaded documents found.
Publication
Altmetrics
Submitted By
PubMed ID
Status
Options
No records to display.
No uploaded documents found.
No protocols found.
Name
Description
Steering Committee
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
Curation Flag Information
Display Stats
New comment to be added:
Flag Active?
OrderID
Experiment
Species
Status
Measurements
Options
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!